starzmegawaysslot| Kangfang Biotech's share price fluctuated sharply: Hong Kong stock biotechnology stocks suffered a setback, with the largest decline of 45%

News summary

Newsletter text

Kangfang Biotech's share price suffersstarzmegawaysslot, triggered a collective decline in Hong Kong stock biotechnology stocks

On May 24, Kangfang Biotech's share price was hit hard by a market rumor that "clinical data fell short of expectations", causing its share price to drop by nearly 45% during the trading day. This negative news quickly spread to the Hong Kong stock market, causing a chain reaction among a series of biotechnology companies. Lepu Biotech's share price fell by more than 11%, and the shares of Columbotai Biotech, Baiji Shenzhou and Kingsressen also fell by more than 8%. In addition, the shares of Rongchang Biotech and Zaiding Pharmaceutical also fell by more than 7%, while the shares of Keji Pharmaceutical and Konoia fell by more than 6%. Lycea Pharmaceutical's share price was also not spared, falling more than 5%.

Tags:

Prev: funkopopdecrashbandicoot| Liu Xuhua, Deputy General Manager of the Business Department of Hunan Bank Head Office, is reviewed and investigated
Next: dragontiger| What is the replacement method for Aiweio spark plugs?